Olivia F Gordon (Olivia Gordon)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Affordable Care Act

Neoadjuvant Chemotherapy

Top Venues

Current oncology (Toronto, Ont.)

Translational andrology and urology

This page only lists publications with an associated author ORCID identifier.

Publications

Ryan M Antar, Vincent E Xu, Oluwafolajimi Adesanya, Arthur Drouaud, Noah Longton, Olivia F Gordon, Kirolos Youssef, Jad Kfouri, Sarah Azari, Sean Tafuri, Briana Goddard, Michael J Whalen
Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer. Current oncology (Toronto, Ont.) 31 (5) (2024)
Ryan M Antar, Vincent E Xu, Christian M Farag, Jack Lucero, Arthur Drouaud, Vinaik Sundaresan, Olivia F Gordon, Sarah Azari, Michael Wynne, Armine K Smith, Michael J Whalen
Oncologic outcomes of neoadjuvant chemotherapy and lymph node dissection with partial cystectomy for muscle-invasive bladder cancer. Translational andrology and urology 13 (8) (2024)
Ryan M Antar, Vincent E Xu, Oluwafolajimi Adesanya, Arthur Drouaud, Noah Longton, Olivia F Gordon, Kirolos Youssef, Jad Kfouri, Sarah Azari, Sean Tafuri, Briana Goddard, Michael J Whalen
Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer. Current oncology (Toronto, Ont.) 31 (5) (2024)
Ryan M Antar, Vincent E Xu, Oluwafolajimi Adesanya, Arthur Drouaud, Noah Longton, Olivia F Gordon, Kirolos Youssef, Jad Kfouri, Sarah Azari, Sean Tafuri, Briana Goddard, Michael J Whalen
Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer. Current oncology (Toronto, Ont.) 31 (5) (2024)